- Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
- NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
- Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
Key statistics
On Tuesday, Cumberland Pharmaceuticals Inc (CPIX:NSQ) closed at 1.51, 5.99% above its 52-week low of 1.42, set on May 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.67 |
---|---|
High | 1.67 |
Low | 1.47 |
Bid | 1.30 |
Offer | 1.95 |
Previous close | 1.51 |
Average volume | 10.80k |
---|---|
Shares outstanding | 14.19m |
Free float | 7.95m |
P/E (TTM) | -- |
Market cap | 21.36m USD |
EPS (TTM) | -0.596 USD |
Data delayed at least 15 minutes, as of May 28 2024 19:06 BST.
More ▼